天邦股份(002124.SZ):擬成立專門的種豬事業部
格隆匯 3 月 15日丨天邦股份(002124.SZ)公佈,公司第七屆董事會第三十二次會議決議,審議通過了《關於成立種豬事業部的議案》;
公司自進入生豬養殖領域以來就非常重視育種工作,擁有國際化育種體系和先進的育種技術,公司的種豬和精液在行業內也有較好的口碑。最近的中央一號文件也提出了“打好種業翻身仗”的號召,為進一步發揮公司的育種優勢,服務我國生豬養殖業、增強公司盈利能力,公司擬成立專門的種豬事業部,由公司副總裁李雙斌掛帥,從組織保障、人員配置、資金支持等方面強化從育種、銷售、服務的一體化能力,成為行業領先的育種企業、優質種源提供者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.